World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 7 September 2021
Main ID:  NCT03154684
Date of registration: 04/05/2017
Prospective Registration: Yes
Primary sponsor: University of Zurich
Public title: Spitex-SpiTal-Autonomie-Reha-Kraft STARK
Scientific title: Efficacy of the STARK Comprehensive Autonomy Health Care Package in Functional Recovery After a Hip Fracture: A Randomized Controlled Trial
Date of first enrolment: May 5, 2017
Target sample size: 5
Recruitment status: Terminated
URL:  https://clinicaltrials.gov/show/NCT03154684
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Double (Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Switzerland
Contacts
Name:     Heike Bischoff-Ferrari, Prof.
Address: 
Telephone:
Email:
Affiliation:  Zentrum Alter und Mobilität
Key inclusion & exclusion criteria

Inclusion Criteria:

- Community-dwelling prior to the hip fracture event

- Living alone or with a partner/family member

- Living in the city of Zurich

- age 70+

- Acute hip or pelvis fracture after minimal trauma (resulting from a fall occurring
from a standard height and without the involvement of others or a vehicle)

- Living at home without or with minimal (i.e. no more than 1x/day) support from the
Spitex (ambulant nursing service) before the hip fracture

- Participant is mentally competent (judicious) based on the treating physicians'
opinion at the screening visit.

- Inpatient rehabilitation or inpatient transitional care at a nursing home or
ambulatory standard of care

- The participant understands the study procedures and voluntarily agree to participate
in the study and comply with all its procedures by giving written informed consent

Exclusion Criteria:

- Patients who are expected to return home without help (i.e. no more care than Spitex
1x/day or physiotherapy 2x/week needed) directly after acute care are excluded.

- Conservative treatment of acute hip fracture or surgical treatment that does not allow
full weight bearing after surgery

- Currently under cancer treatment or has active cancer (except for non-melanoma skin
cancer)

- Major visual or hearing impairment (visual and/or hearing aids are allowed) or other
serious illness that would preclude participation

- 24-hour nursing care need as this cannot be offered within the STARK package

- Mobility impairment that precludes return to own apartment

- Planned nursing home admission after acute hospital stay

- Current participation in another clinical trial, or plans of such participation in the
next 12 months (corresponding to the study duration)

- Inability to read and/or speak German to an extent necessary to understand
instructions and participate in the study

- Unwilling to forego any additional vitamin D supplementation (bolus or regular
intake).



Age minimum: 70 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Osteoporosis
Hip Fractures
Frailty
Intervention(s)
Other: STARK intervention
Other: Standard of Care
Primary Outcome(s)
Lower extremity function [Time Frame: 12 months]
Secondary Outcome(s)
Number of re-hospitalizations [Time Frame: 12 months]
Quality of life [Time Frame: 12 months]
Rate of falls [Time Frame: 12 months]
Health care utilization [Time Frame: 12 months]
Cognitive function [Time Frame: 12 months]
Bone mineral density [Time Frame: 12 months]
Number of nursing home admissions [Time Frame: 12 months]
Adherence to preventive strategies [Time Frame: 3 months]
Repeated sit-to-stand [Time Frame: 12 months]
Gait speed [Time Frame: 12 months]
Activities of daily living [Time Frame: 12 months]
Adherence to preventive strategies [Time Frame: 12 months]
Appendicular muscle mass [Time Frame: 12 months]
Grip strength [Time Frame: 12 months]
Secondary ID(s)
2016-01820
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Applied Sciences of Western Switzerland
City of Zurich, Switzerland
Ebnet Stiftung, Switzerland
Spitex Zürich, Switzerland
University Hospital, Zürich
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history